The Corner Office


Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at

Product Description

A review of the annual reports and public statements of more than two dozen of the industry’s publicly traded
pharmaceutical/biotechnology companies reveals the top trends as identified by the CEOs,
presidents, and executive management teams of these industry standard bearers.

Industry Experts
Miles D. White, Chairman of the Board and CEO, Abbott
David E. I. Pyott, Chairman and CEO, Allergan
Kevin W. Sharer, Chairman and CEO, Amgen
Masafumi Nogimori, President and CEO, Astellas
David R. Brennan, CEO, AstraZeneca
Robert L. Parkinson Jr., Chairman and CEO, Baxter
Werner Wenning, Chairman of the Board of Management, Bayer AG
James C. Mullen, President and CEO, Biogen
Christian Boehringer, Chairman of the Shareholders Committee, Boehringer Ingelheim
James M. Cornelius, Chairman and CEO, Bristol-Myers Squibb
Dr. Brian McNamee, CEO and Managing Director, CSL Behring
Kiyoshi Morita, Representative Director and Chairman, Daiichi Sankyo
Takashi Shoda, Representative Director, President, and CEO, Daiichi Sankyo
Hajime Shimizu, Chairman and CEO, Eisai Corporation of North America
Arthur D. Levinson, Ph.D., Chairman and CEO, Genentech
Henri A. Termeer, President and CEO, Genzyme
Andrew Witty, CEO, GlaxoSmithKline
William C. Weldon, Chairman and CEO, Johnson & Johnson
John C. Lechleiter, Ph.D., President and CEO, Lilly
Dick Clark, Chairman, President, and CEO, Merck
Daniel Vasella, M.D., Chairman and CEO, Novartis
Lars Rebien Sørensen, President and CEO, Novo Nordisk
Jeff Kindler, Chairman of the Board and CEO, Pfizer
Severin Schwan, CEO, Roche Group, Roche
Gérard Le Fur, CEO, Sanofi-Aventis
Fred Hassan, Chairman and CEO, Schering-Plough
Roch Doliveux, CEO, UCB
Bernard Poussot, Chairman, President, and CEO, Wyeth